Virginia Retirement Systems’s Janux Therapeutics JANX Stock Holding History

Virginia Retirement Systems’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Buy	+11,350	New	+$164K	﹤0.01%	1270

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Virginia Retirement Systems's JANX Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Janux Therapeutics (JANX) in Q2 2026: 11,350 shares worth $174K. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings.

198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Virginia Retirement Systems held 11,350 shares of Janux Therapeutics worth $174K as of Q2 2026.
Janux Therapeutics was a new Virginia Retirement Systems position in Q2 2026.
Janux Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1270 holding.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.